Beta Bionics, Inc. SEC filings BBNX
Beta Bionics, Inc. has 285 filings in SEC EDGAR's recent list, going back to May 16, 2016. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 27, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 27, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 27, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Other events
|
Sep 17, 2026 | Sep 15, 2026 |
| 424B5 | Prospectus supplement | Sep 17, 2026 | — |
| FWP | Free writing prospectus | Sep 16, 2026 | — |
| 424B5 | Prospectus supplement | Sep 16, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 15, 2026 | Sep 14, 2026 |
| 10-Q | Quarterly report | Jul 29, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 29, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 22, 2026 | May 21, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 21, 2026 | May 21, 2026 |
| 10-Q | Quarterly report | Apr 21, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 21, 2026 | Apr 21, 2026 |
| ARS | Annual report to shareholders | Apr 10, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 10, 2026 | — |
| DEF 14A | Proxy statement | Apr 10, 2026 | May 21, 2026 |
| S-3ASR | Automatic shelf registration | Feb 24, 2026 | — |
| S-8 | Employee stock plan registration | Feb 24, 2026 | — |
| 10-K | Annual report | Feb 24, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 17, 2026 | Feb 17, 2026 |
| 8-K |
Current report
Other events
|
Jan 30, 2026 | Jan 29, 2026 |
| 8-K |
Current report
Results of operations
|
Jan 8, 2026 | Jan 8, 2026 |
| 10-Q | Quarterly report | Oct 28, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 28, 2025 | Oct 28, 2025 |
| 10-Q | Quarterly report | Jul 29, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Jul 29, 2025 | Jul 29, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 23, 2025 | Jun 22, 2025 |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| 10-K/A | Amended annual report | Mar 28, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 27, 2025 | Mar 26, 2025 |
| 10-K | Annual report | Mar 25, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2025 | Mar 25, 2025 |
| S-8 | Employee stock plan registration | Feb 3, 2025 | — |
| 8-K |
Current report
Unregistered share sale, Bylaw or fiscal year change, Other events
|
Jan 31, 2025 | Jan 31, 2025 |
| 424B4 | Prospectus | Jan 31, 2025 | — |
| SEC STAFF LETTER | Filing | Jan 29, 2025 | — |
| EFFECT | Filing | Jan 29, 2025 | — |
| S-1MEF | Filing | Jan 29, 2025 | — |
| CERT | Filing | Jan 29, 2025 | — |
| CORRESP | Letter to the SEC | Jan 28, 2025 | — |
| CORRESP | Letter to the SEC | Jan 28, 2025 | — |
| S-1/A | Amended registration statement | Jan 28, 2025 | — |
| 8-A12B | Filing | Jan 27, 2025 | — |
| CORRESP | Letter to the SEC | Jan 23, 2025 | — |
| S-1/A | Amended registration statement | Jan 23, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 22, 2025 | — |
| S-1/A | Amended registration statement | Jan 22, 2025 | — |
| CORRESP | Letter to the SEC | Jan 10, 2025 | — |
| CORRESP | Letter to the SEC | Jan 6, 2025 | — |
| S-1 | Registration statement | Jan 6, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 19, 2024 | — |
| DRS/A | Filing | Dec 16, 2024 | — |
| DRSLTR | Filing | Dec 13, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 6, 2024 | — |
| DRS/A | Filing | Nov 25, 2024 | — |
| DRSLTR | Filing | Nov 22, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 6, 2024 | — |
| SEC STAFF LETTER | Filing | Oct 31, 2024 | — |
| DRS/A | Filing | Oct 28, 2024 | — |
| DRSLTR | Filing | Oct 25, 2024 | — |
| SEC STAFF LETTER | Filing | Oct 22, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 10, 2024 | — |
| DRS | Filing | Sep 13, 2024 | — |
| C-AR | Filing | Apr 25, 2024 | Dec 31, 2023 |
| D | Filing | Sep 15, 2023 | — |
| C-AR | Filing | Apr 26, 2023 | Dec 31, 2022 |
| C-AR/A | Filing | Sep 1, 2022 | Dec 31, 2021 |
| C-AR | Filing | Apr 29, 2022 | Dec 31, 2021 |
| D | Filing | Mar 2, 2022 | — |
| C-AR/A | Filing | May 14, 2021 | Dec 31, 2020 |
| C-AR | Filing | Apr 30, 2021 | Dec 31, 2020 |
| C-AR/A | Filing | May 22, 2020 | Dec 31, 2019 |
| C-AR | Filing | Apr 29, 2020 | Dec 31, 2019 |
| D | Filing | Jul 22, 2019 | — |
| C-AR | Filing | Apr 30, 2019 | Dec 31, 2018 |
| D/A | Filing | Oct 23, 2018 | — |
| D/A | Filing | Sep 17, 2018 | — |
| C-AR | Filing | Apr 30, 2018 | Dec 31, 2017 |
| D | Filing | Dec 27, 2017 | — |
| C-AR | Filing | May 1, 2017 | Dec 31, 2016 |
| C-U | Filing | Sep 9, 2016 | — |
| C/A | Filing | Aug 26, 2016 | — |
| C/A | Filing | Aug 23, 2016 | — |
| C | Filing | May 16, 2016 | — |
Showing 85 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- BBNX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Irvine, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1674632
- Former names
- Beta Bionics, Inc (until Jan 6, 2025)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.